Prothena Corp PLC
(LTS:0Y3M)
$
8.1
-0.28 (-3.36%)
Market Cap: 424.85 Mil
Enterprise Value: 103.04 Mil
PE Ratio: 0
PB Ratio: 1.38
GF Score: 73/100 Prothena Corporation PLC at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 05:00PM GMT
Release Date Price:
$71.98
(+0.96%)
Mike Yee
Jefferies - Analyst
All right. Thank you for joining us on the next session here at the Jefferies Healthcare Conference. I'm Mike Yee, Managing Director and senior biotechnology analyst. And I have the pleasure of having the President and CEO of Prothena up here with us, Gene Kinney. Thanks for joining us, Gene.
Gene Kinney
Prothena Corporation plc - President, CEO & Director
Thanks for having us, Mike.
Mike Yee
Jefferies - Analyst
Absolutely. You have done a fantastic job building out a whole portfolio of products, specifically a pipeline of products, particularly around neurodegenerative diseases, protein misfolding, and we'll get to even vaccination as well for neurodegeneration.
Gene Kinney
Prothena Corporation plc - President, CEO & Director
Yup.
Questions & Answers
Mike Yee
Jefferies - Analyst
And so there's a lot to talk about. I would love to just start off first by asking about your
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot